-

Medical Devices

  • Share Share this page

2004 FDA Workshop on Pre-Clinical Testing for Endovascular Grafts - July 28 - 29, 2004

PDF Printer Version

 

 

Thanks to all who attended and participated in the 2004 Workshop on Pre-Clinical Testing for Endovascular Grafts. Please refer to the Workshop agenda for the proceedings and outcome of the meeting.

 Conference Overview

We are pleased to announce the second FDA Workshop on Preclinical Testing for Endovascular Grafts.

Dates: July 28 - 29, 2004
Location: Hilton Washington, DC North in Gaithersburg, MD


FDA Steering Committee:

Dorothy B. Abel
Marianne Grunwaldt
Angela C. Smith

Scientific Advisory Committee:

Mark M. Dehdashtian
Stuart T. Rodger
Louis J. Smith
Matthew S. Waninger, PhD

As with the previous meeting, representatives from various areas involved with the development, testing and use of endovascular grafts have been invited. There will be four sessions during the workshop:

  1. Animal studies;
  2. Fixation effectiveness and sealing;
  3. Implant integrity; and
  4. Past, present and future issues in pre-clinical testing.

Each session will begin with short presentations followed by discussion from the participants and audience.

 Venue and Location

The 2004 FDA Workshop on Preclinical Testing for Endovascular Grafts will be held at the Hilton Washington, DC North, located at 620 Perry Parkway in Gaithersburg, MD. For more information and for reservations please call: 301-977-8900 or visit the Hilton Hotels web site at www.hilton.com.

 Participation

Participation in the Workshop will consist of both invited participants and audience members. The invited participants include representatives from various areas involved with the development of endovascular grafts such as industry, the medical community and testing facilities. Invited participants will complete a work assignment in advance of the meeting in order to optimize the time spent during the workshop. There will be a limit of two participants per organization at each of the four sessions with a total of eight participants per organization. Audience participation is open to all who are interested in the pre-clinical testing of endovascular grafts and will be scheduled throughout the sessions.

 Attire

The attire for both days will be business casual.

 Sponsors

The Workshop is sponsored by the Food and Drug Administration and the Center for Devices and Radiological Health.

 Additional Information

Angela Smith
angela.smith@fda.hhs.gov
301-443-8517, extension 109

Workshop Objectives
Workshop Agenda

    
-
-
-
-
-